Beijing, China
Research view
Cervical cancer: who works on it
Groups that published on this disease or run trials on it, from public registries and publications. Researchers appear by name only once their profile is published.
Find fellow researchers
One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.
- All targets
- TP53 2
- PD-1 19
- PD-L1 12
- PI3K 3
- AKT 1
- CTLA-4 7
- HER2 9
- CTNNB1 0
- mTOR 0
- STAT3 0
- VEGF 3
- EGFR 2
- MAPK 0
- MYC 0
- PTEN 2
- NRF2 1
- PIK3CA 3
- ERK 0
- PARP 0
- AMPK 0
- JAK 0
- TROP2 4
- YAP 0
- BRCA1 2
- GPX4 0
- HIF-1 0
- IL-6 0
- TNF 0
- FOXP3 0
- KRAS 0
- B7-H3 3
- BCL-2 0
- BRCA2 2
- HER3 1
- JNK 0
- MMP-9 0
- STING 0
- STK11 0
- AXL 0
- CD47 0
- COX-2 0
- EZH2 0
- FAK 1
- HDAC 0
- HMGB1 0
- PPAR 0
- PRAME 0
- ATM 0
- CD40 0
- CXCR4 0
- IDH 1
- LAG-3 0
- METTL3 0
- NF1 0
- NOTCH1 0
- PKM2 0
- PRMT5 0
- SHP2 0
- SIRT1 0
- ALK 0
EU-13 is a filter, not a ranking: it only narrows the list.
Houston, United States
Fuzhou, China
Ürümqi, China
Wuhan, China
Shanghai, China
Paris, France
Shanghai, China
Cambridge, United States
Stockholm, Sweden
Toronto, Canada
Hangzhou, China
Baltimore, United States
Chengdu, China
Chapel Hill, United States
Beijing, China
Seattle, United States
São Paulo, Brazil
Nanjing, China
London, United Kingdom
Rome, Italy
Bethesda, United States
Chennai, India
Lyon, France
24 of 2,705 institutions, ordered by recent publications and open trials. This is not a ranking of quality.
Who stopped a trial, and why
Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.
Suspended
A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers
“PI Request”Registry text, quoted unchanged. Source
Terminated
“PI Request”Registry text, quoted unchanged. Source
Terminated
“Sponsor decision.”Registry text, quoted unchanged. Source
Suspended
CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors
“Sponsor stopped the study.”Registry text, quoted unchanged. Source
Terminated
Impact of Basic Needs Assessment and Support to Improve Colposcopy Show Rate
“Staffing issues”Registry text, quoted unchanged. Source
Withdrawn
“Study withdrawn prior to participant enrollment due to lack of study product.”Registry text, quoted unchanged. Source
Suspended
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
“Funding”Registry text, quoted unchanged. Source
Terminated
“Following completion of Phase 1b, the Sponsor decided not to initiate Part 2 of the trial.”Registry text, quoted unchanged. Source
Terminated
“No superior PFS in study group among the enrolled patients. Company R\&D strategy shifted; funding discontinued, study terminated.”Registry text, quoted unchanged. Source
Terminated
“Strategic decision by Sponsor.”Registry text, quoted unchanged. Source
Trials that share participant data
Trials whose registry record says individual participant data (IPD) will be shared.
Search by method
Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.
- Single-Cell Analysis 28
- Organoids 10
- Mendelian Randomization Analysis 13
- CRISPR-Cas Systems 21
- Gene Expression Profiling 68
- Sequence Analysis, RNA 5
- Whole Genome Sequencing 1
- Exome Sequencing 3
- Proteomics 17
- Metabolomics 9
- Mass Spectrometry 3
- Flow Cytometry 25
- Immunohistochemistry 46
- Liquid Biopsy 8
- Circulating Tumor DNA 6
- Xenograft Model Antitumor Assays 65
- Positron-Emission Tomography 14
- Magnetic Resonance Imaging 92
- Machine Learning 63
- Deep Learning 49
- Cohort Studies 81
- Genome-Wide Association Study 14
Paste an abstract
See which targets of this disease your abstract mentions, and go to the people working on them.
Matched in your browser only. The text is not sent, saved or logged.
Sources: ClinicalTrials.gov, EU CTR, OpenAlex, PubMed. Machine-matched links are labelled.